SOLICITATION NOTICE
A -- Atopic Derrmatitis Research Network: Statistical and Clinical Coordinating Center
- Notice Date
- 6/1/2009
- Notice Type
- Presolicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- RFP-NIAID-DAIT-NIHAI2009063
- Archive Date
- 10/31/2009
- Point of Contact
- MyLinh Pham, Phone: 301-496-0993, David T Lisle, Phone: 301-451-2617
- E-Mail Address
-
phamm@exchange.nih.gov, dlisle@niaid.nih.gov
(phamm@exchange.nih.gov, dlisle@niaid.nih.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID, Division of Allergy, Immunology, and Transplantation (DAIT) has a requirement for capabilities and facilities to establish and manage a Statistical and Coordinating Center to provide support for the Atopic Diseases Research Network clinical studies and clinical trials Research supported and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), strives to better understand, treat, and ultimately prevent immunologic, infectious, and allergic diseases. The NIAID Division of Allergy, Immunology, and Transplantation (DAIT) supports extramural basic, pre-clinical and clinical research focusing on immune-mediated diseases through a variety of research grants and contracts. This includes support for clinical research to evaluate the safety and efficacy of therapeutic and preventive approaches and agents and to elucidate the underlying mechanisms of such approaches and agents. This requirement for the Statistical and Data Coordinating Center (SDCC) for the Atopic Dermatitis Research Network provides critical services for the design, implementation, oversight (including regulatory support and compliance, safety and clinical site monitoring and reporting, training, and distribution and quality control of study products), and analysis of DAIT, NIAID-supported Atopic Dermatitis Research Network clinical studies and clinical trials and associated mechanistic studies being conducted by this group. The purpose of the Atopic Dermatitis Research Network (ADRN) is to study the defense mechanisms of the skin, with research focused on atopic dermatitis (AD) and its association with both immune and skin barrier defects (compared to non-atopic individuals). Specific research areas may include the defects resulting in susceptibility to eczema vaccinatum (EV) and eczema herpeticum (EH), and to colonization and infection with Staphylococcus aureus (SA) (including methicillin-resistant Staphylcoccus aureus, MRSA), and responsiveness of AD subjects to vaccines. It is anticipated that research conducted within the ADRN will utilize state of the art techniques to measure immune responses and skin barrier function, and will capitalize on new scientific opportunities and advancements in the field. The ADRN will support multi-disciplinary teams that include qualified personnel committed to the project in areas proposed. This is likely to include immunologists, virologists, bacteriologists, geneticists, dermatologists and allergists. This Network was originally established as the Atopic Dermatitis and Vaccinia Network (ADVN), consisting of three contracts: a Clinical Studies Consortium, an Animal Studies Consortium and a Statistical and Data Coordinating Center These three contracts were originally funded from 2004-2009, and the contracts were then extended until 2010. The ADVN has been focused on the pathogenesis of EV, with the ultimate goal of reducing the severity of EV, but the new solicitation extends the scope of the Network to the research areas described above. The initial ADVN SDCC contract was awarded to Rho Federal Systems, Inc. in 2004 (Contract Number HHSN26620040033C ) and has served to provide a broad range of clinical research support services to the ADVN. Under this contract, those services will be continued and will also be expanded to provide support for the expanded research areas of the new Atopic Dermatitis Research Network. It is anticipated one cost reimbursement completion type contract will be awarded for a period of five years, beginning approximately June 30, 2010. It is estimated that the provision of FTEs will be approximately 8.25 FTE’s. Any responsible offeror may submit a proposal which will be considered by the Agency. This RFP will be available electronically on/about June 16, 2009, and may be accessed through FedBizOpps http://www.fedbizopps.gov/. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIAID-DAIT-NIHAI2009063/listing.html)
- Place of Performance
- Address: United States
- Record
- SN01832239-W 20090603/090601234733-0295e51cfc729e6212f9bd0c07f529e0 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |